Patent · US Active

Use of 4-oxobutanoic acid derivatives in the treatment of inflammation

US7897644B2 · kind B2 · utility

0Cited by

6References

12Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Gerard Moinet · Orsay, FR
Dominique Marais · Gagny, FR
Philippe Maizeray · Vanves, FR

Key dates

Filing date	Nov 6, 2002
Grant date	Mar 1, 2011
Priority date	—
Expiry date	Apr 25, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the use of a 4-oxobutanoic acid derivative for the preparation of a pharmaceutical composition for treating inflammation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.